Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer

por Corcoran, N M, Hovens, C M, Michael, M, Rosenthal, M A, Costello, A J
Publicado 2010

Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours

por Price, T J, Lipton, L, McGreivy, J, McCoy, S, Sun, Y-N, Rosenthal, M A
Publicado 2008

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

por McKeage, M J, Von Pawel, J, Reck, M, Jameson, M B, Rosenthal, M A, Sullivan, R, Gibbs, D, Mainwaring, P N, Serke, M, Lafitte, J-J, Chouaid, C, Freitag, L, Quoix, E
Publicado 2008